CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,624 | +118.3% | 19,292 | +85.2% | 0.00% | – |
| Q2 2023 | $134,509 | -71.5% | 10,419 | -81.7% | 0.00% | -100.0% |
| Q1 2023 | $471,919 | +52.2% | 57,064 | +104.3% | 0.00% | 0.0% |
| Q1 2021 | $310,000 | -18.4% | 27,926 | -8.3% | 0.00% | -33.3% |
| Q4 2020 | $380,000 | -34.3% | 30,455 | -42.9% | 0.00% | -62.5% |
| Q3 2020 | $578,000 | -4.9% | 53,299 | -2.3% | 0.01% | -20.0% |
| Q2 2020 | $608,000 | +560.9% | 54,553 | +335.1% | 0.01% | +400.0% |
| Q1 2020 | $92,000 | – | 12,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |